EL

Eric Le Bris

Director Director Appointed In Casual Vacancy DIN 01359204
DIN 01359204 First appointment Mar 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2007
Shareholding value •••• Premium profile

About Eric Le Bris

Data last updated:

Eric Le Bris was a Director Appointed In Casual Vacancy at Sanofi-Synthelabo (India) Private Limited (2007–2010) and Additional Director at Sanofi India Limited (2007–2009). The companies operate in Pharma.

DIN 01359204
Primary Designation Director Appointed In Casual Vacancy
Industry Pharma
First Appointment 16 Mar 2007

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director Appointed In Casual Vacancy20 Mar 20072002₹729 Cr (FY 2020)Amalgamated
Sanofi India Limited L24239MH1956PLC009794
Additional Director16 Mar 20071956₹2,916 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sanofi-Synthelabo (India) Private Limited
Sanofi India Limited
Premium access

Shareholding and investment profile for Eric Le Bris

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Eric Le Bris

Eric Le Bris was first appointed on 16 Mar 2007 as Additional Director at Sanofi India Limited.

Eric Le Bris held 2 earlier board appointments: Sanofi-Synthelabo (India) Private Limited (Director Appointed In Casual Vacancy, 20 Mar 2007 to 12 Jul 2010); Sanofi India Limited (Additional Director, 16 Mar 2007 to 27 Oct 2009).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available